XASEYCBDpA
Market cap1mUSD
Sep 20, Last price
-139.63USD
Name
Level Brands Inc
Profile
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
Income | ||||||||||
Revenues | 19,482 -19.35% | 24,155 -31.77% | 35,403 -20.41% | |||||||
Cost of revenue | 20,149 | 25,924 | 44,950 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (667) | (1,768) | (9,547) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 4,002 | |||||||||
Tax Rate | ||||||||||
NOPAT | (667) | (1,768) | (13,549) | |||||||
Net income | (3,700) -83.87% | (22,938) -69.04% | (74,086) 216.67% | |||||||
Dividends | (3,668) | (4,002) | ||||||||
Dividend yield | 175.27% | 1,338.98% | ||||||||
Proceeds from repurchase of equity | 50 | 2,478 | ||||||||
BB yield | -2.47% | -118.40% | ||||||||
Debt | ||||||||||
Debt current | 1,270,103 | 1,280 | 1,188 | |||||||
Long-term debt | 99 | 6,084 | 8,539 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 90 | 401 | ||||||||
Net debt | 1,267,049 | 4,865 | 607 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (353) | (4,302) | (14,967) | |||||||
CAPEX | (190,015) | (298) | (689) | |||||||
Cash from investing activities | (290) | 702 | (689) | |||||||
Cash from financing activities | 1,298 | (1,323) | (4,035) | |||||||
FCF | 7,347,227 | 1,023 | (11,231) | |||||||
Balance | ||||||||||
Cash | 2,453 | 1,798 | 7,720 | |||||||
Long term investments | 700 | 700 | 1,400 | |||||||
Excess cash | 2,178 | 1,290 | 7,350 | |||||||
Stockholders' equity | (182,058,959) | (174,356) | (147,358) | |||||||
Invested Capital | 174,721,603 | 187,160 | 184,052 | |||||||
ROIC | ||||||||||
ROCE | 0.01% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 4,313 | 2,022 | 1,328 | |||||||
Price | 0.47 -54.59% | 1.04 359.80% | 0.23 -89.18% | |||||||
Market cap | 2,027 -3.16% | 2,093 600.31% | 299 -88.23% | |||||||
EV | 1,274,076 | 6,963 | 911 | |||||||
EBITDA | 1,154 | 1,159 | (6,576) | |||||||
EV/EBITDA | 1,104.38 | 6.01 | ||||||||
Interest | 16 | |||||||||
Interest/NOPBT |